GGrantIndex
Sort

261,768 grants matching gene therapy

Columbus NCORP RFA-CA-18-016

$1,315,168
William A Wilson · Columbus Community Clinical Oncology Prg · UG1 · FY2023 · CA

Program Project: The Pathogenesis of HIV-Associated Nephropathy

$1,315,073
Paul Evan Klotman · Baylor College Of Medicine · P01 · FY2013 · DK

Role of co-receptor modified cells in HIV infection

$1,314,844
Carl H. June · University Of Pennsylvania · U01 · FY2013 · AI

Comparative Modeling: Informing Breast Cancer Control Practice & Policy

$1,314,797
Jeanne Mandelblatt · Georgetown University · U01 · FY2014 · CA

Pathogenesis of Rett Syndrome

$1,314,757
Sakkubai R Naidu · Hugo W. Moser Res Inst Kennedy Krieger · P01 · FY2007 · HD

ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR HIV/AIDS

$1,314,596
Miriam Hospital · U01 · FY2003 · AI

Comprehensive multimodal analysis of patients with neuroimmunological diseases

$1,314,593
Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS

Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies

$1,314,516
Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Signal Transduction in Epithelial Cancer Cells

$1,314,511
Stanley Lipkowitz · Clinical Sciences · Z01 · FY2007 · CA

Early Pathogenesis of Cystic Fibrosis Related Diabetes

$1,314,318
John F Engelhardt · University Of Iowa · R24 · FY2012 · DK

Gene Targets for Intraventricular Hemorrhage (IVH)

$1,314,166
Laura R. Ment · Yale University · R01 · FY2011 · NS

Receptor -directed therapy

$1,314,117
John Janik · Basic Sciences · Z01 · FY2007 · CA

Mechanisms of Peripheral Induction of T-Cell Tolerance

$1,314,073
Matthew F Mescher · University Of Minnesota · P01 · FY2008 · AI

NIDCD Core for Clinical Research and Care

$1,314,049
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2010 · DC

TIM recognition of phosphatidylserine regulates innate and adaptive immunity

$1,313,791
Dale T Umetsu · Boston Children'S Hospital · P01 · FY2010 · AI

CTO1681 to prevent and mitigate cytokine release syndrome in multiple myeloma patients receiving CAR T-cell therapy

$1,313,567
Arthur P Bertolino · Cytoagents, Inc. · R44 · FY2025 · CA

Multi-scale modeling of inherited pediatric cardiomyopathies

$1,313,504
Kevin Kit Parker · Harvard University · UG3 · FY2017 · HL

Functional Genomics of Human Brain Development

$1,313,408
Nenad Sestan · Yale University · P50 · FY2015 · MH

FORMULATION OF RATIONAL THERAPY OF NEPHROLITHIASIS

$1,313,325
University Of Texas Sw Med Ctr/Dallas · P01 · FY2001 · DK

Clinical trials of gene therapy for Leber congenital amaurosis

$1,313,291
Samuel G Jacobson · University Of Pennsylvania · U10 · FY2010 · EY

Molecular mechanisms of liver injury, repair, and immunity

$1,313,140
Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA

Computational and Experimental RNA Nanobiology

$1,312,847
Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

In vivo Pathway Discovery in Autosomal Dominant Polycystic Kidney Disease

$1,312,677
Stefan Somlo · Yale University · RC2 · FY2021 · DK

Oxidative Stress, AMPK &Diabetic Cardiovascular Disease

$1,312,516
Boston Medical Center · P01 · FY2003 · HL

Molecular Tumorigenesis of Bladder Cancer

$1,312,471
Xue-Ru Wu · New York University School Of Medicine · P01 · FY2015 · CA